Collegium Pharmaceutical paid its 6 named executives $17.4M in total in FY2025 (Dec). CEO Vikram Karnani was paid $1.7M of that.
Pay$100 in the stock at the end of FY21 → $248
Pay of each named executive
David DieterExecutive Vice President and General Counsel
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | Not disclosed |
3 years
Colleen TupperExecutive Vice President and Chief Financial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Scott DreyerExecutive Vice President and Chief Commercial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Shirley KuhlmannFormer Executive Vice President, Chief Administrative Officer, General Counsel and Secretary
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Thomas Smith, M.D.Executive Vice President and Chief Medical Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Vikram KarnaniPresident and Chief Executive Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed |
4 years
CEO pay against the pay peers
In FY2024 (Dec), the median CEO pay of the 8 peers with pay on file was $7.7M. CEO pay of Collegium Pharmaceutical for that year is not on file.
- 1Supernus Pharmaceuticals
- 2Pacira BioSciences
- 3Ani Pharmaceuticals
- 4Amphastar Pharmaceuticals
- 5Acadia Pharmaceuticals
- 6Harmony Biosciences Holdings
- 7Travere Therapeutics
- 8Innoviva
- 9Collegium PharmaceuticalThis companyNot disclosed
- 10Amarin Corporation PLCNot disclosed
- 11Anika Therapeutics, Inc.Not disclosed
- 12Biocryst PharmaceuticalsNot disclosed
- 13Catalyst Pharmaceuticals, Inc.Not disclosed
- 14Corcept TherapeuticsNot disclosed
- 15Dynavax Technologies CorporationNot disclosed
- 16Eagle Pharmaceuticals, Inc.Not disclosed
- 17Intercept Pharmaceuticals, Inc.Not disclosed
- 18Ironwood Pharmaceuticals, Inc.Not disclosed
- 19Vanda Pharmaceuticals Inc.Not disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.